Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|June 1, 1980
MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activitiesH Kropp, J G Sundelof, J S Kahan, et al.Antimicrobial Agents and Chemotherapy|August 1, 1997
Pharmacokinetics of L-749,345, a long-acting carbapenem antibiotic, in primatesJ G Sundelof, R Hajdu, C J Gill, et al.Antimicrobial Agents and Chemotherapy|March 1, 1996
Pharmacokinetics in nonhuman primates of a prototype carbapenem active against methicillin-resistant Staphylococcus aureusJ G Sundelof, R Thompson, K M White, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1986
Oxidative and defluorinative metabolism of fludalanine, 2-2H-3-fluoro-D-alanineG K Darland, R Hajdu, H Kropp, et al.Antimicrobial Agents and Chemotherapy|May 1, 1995
In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373K Bartizal, T Scott, G K Abruzzo, et al.Antimicrobial Agents and Chemotherapy|May 1, 1999
In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolatesJ Kohler, K L Dorso, K Young, et al.Antimicrobial Agents and Chemotherapy|October 1, 1972
Cephamycins, a new family of beta-lactam antibiotics. IV. In vivo studiesA K Miller, E Celozzi, Y Kong, et al.Antimicrobial Agents and Chemotherapy|November 26, 1997
Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)R Hajdu, R Thompson, J G Sundelof, et al.Frontiers in Neurology|February 7, 2022
Active Middle Ear Implant Evoked Auditory Brainstem Response Intensity-Latency CharacteristicsLaura Fröhlich, Alexander Müller, Miriam H Kropp, et al.Pageof 5